Daily Archives: May 2, 2012

Swedish study overturns US epidemiology.

Posted on May 2, 2012 by researchinitiative

Parental Socioeconomic Status and Risk of Offspring Autism Spectrum Disorders in a Swedish Population-Based Study http://www.sciencedirect.com/science/article/pii/S0890856712001001 “Epidemiological studies in the United States consistently find autism spectrum disorders (ASD) to be overrepresented in high socio economic status (SES) families. These findings … Continue reading →

Posted in Autism, Environment, Epidemiology, Epigenetics, General, Genetics | Leave a comment

Genetic Networks in Autism.

Posted on May 2, 2012 by researchinitiative

Networks of Neuronal Genes Affected by Common and Rare Variants in Autism Spectrum Disorders http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1002556 Author Summary “Autism spectrum disorders (ASD) are neurodevelopmental syndromes with a strong genetic basis, but are influenced by many different genes. Recent studies have identified … Continue reading →

Posted in Autism, Environment, Epigenetics, General | Leave a comment

The Importance of Environment – Medical Heresy.

Posted on May 2, 2012 by researchinitiative

“Our conclusions may sound obvious or benign, but they may also be viewed as medical heresy,” says Bruce Lanphear, the study’s SFU co-author. The health scientist was also involved in studies showing that there is no safe level of lead … Continue reading →

Posted in Allergy, Asthma, Autism, co-morbid, Environment, Epigenetics, General, Genetics, Immune System, Inflammation, Physiology, Treatment | Leave a comment

ASD, GI and Regression

Posted on May 2, 2012 by researchinitiative

“On 13 February, SFARI hosted a workshop to explore whether regression is unique to some children affected by autism. Basic science and clinical researchers from around the world met to share and discuss current research and ideas. The participants concluded … Continue reading →

Posted in Autism, co-morbid, Environment, General, Gut, Immune System, Inflammation, Mice, Neurology, Physiology, Treatment | Leave a comment

Muscular Dystrophy and Autism – Part II

Posted on May 2, 2012 by researchinitiative

Interesting readings. Effect of NF-κB inhibition on AAV9 minidystrophin gene transfer to the mdx mouse. Neurology Service, Department of Veterans Affairs Medical Center, Pittsburgh, PA, USA Department of Neurology, University of Pittsburgh Increased muscle expression of interleukin-17 in Duchenne muscular … Continue reading →

Posted in Autism, co-morbid, General, Genetics, Inflammation, Mice, Muscular Dystrophy, Neurology, Physiology | 1 Comment

Pfizer and Fragile X treatment – Update

Posted on May 2, 2012 by researchinitiative

One of our readers responded in a previous thread … https://asdresearchinitiative.wordpress.com/2012/04/28/quick-post-pfizer-develops-new-fragile-x-drug/ “If they wanted to test this drug for efficacy on fragile X, why didn’t they test it on a fragile X mouse model?” I emailed the gist of that … Continue reading →

Posted in Autism, co-morbid, Environment, Epigenetics, General, Genetics, Mice, Neurology, Treatment | Leave a comment